FDA NDC Directory · JSON-LD · Markdown

Skyrizi

NDC 0074-1065 · HUMAN PRESCRIPTION DRUG · KIT

Generic nameRisankizumab-rzaa
Labeler / ManufacturerAbbVie Inc.
Marketing categoryBiologic License Application · App BLA761105
Dosage form / routeKIT · INTRAVENOUS
Active ingredients—
Marketing started20220923
Package count2

External sources

Source: openFDA. Public-domain (CC0).